{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.3616.200.110.102.1014",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2022-07-13T01:02:20.000-04:00"
  },
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.1014",
  "version" : "20220713",
  "name" : "Casirivimab / Imdevimab Administration",
  "status" : "active",
  "date" : "2022-07-13T01:02:20-04:00",
  "publisher" : "Clinical Architecture",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2022",
      "concept" : [{
        "code" : "M0240",
        "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses"
      },
      {
        "code" : "M0241",
        "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses"
      },
      {
        "code" : "M0243",
        "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring"
      },
      {
        "code" : "M0244",
        "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency"
      },
      {
        "code" : "Q0240",
        "display" : "Injection, casirivimab and imdevimab, 600 mg"
      },
      {
        "code" : "Q0243",
        "display" : "Injection, casirivimab and imdevimab, 2400 mg"
      },
      {
        "code" : "Q0244",
        "display" : "Injection, casirivimab and imdevimab, 1200 mg"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:8c4fffd4-6875-417c-89cd-b73e3f4f2c01",
    "timestamp" : "2022-09-28T05:22:47-04:00",
    "total" : 7,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2022",
      "code" : "M0240",
      "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2022",
      "code" : "M0241",
      "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2022",
      "code" : "M0243",
      "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2022",
      "code" : "M0244",
      "display" : "Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2022",
      "code" : "Q0240",
      "display" : "Injection, casirivimab and imdevimab, 600 mg"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2022",
      "code" : "Q0243",
      "display" : "Injection, casirivimab and imdevimab, 2400 mg"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
      "version" : "2022",
      "code" : "Q0244",
      "display" : "Injection, casirivimab and imdevimab, 1200 mg"
    }]
  }
}